Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Published:2018-06-14 Issue:12 Volume:2 Page:1393-1402
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Ali Abdullah Mahmood¹,Huang Yumin²³,Pinheiro Ronald Feitosa¹,Xue Fumin²,Hu Jingping²,Iverson Nicholas¹,Hoehn Daniela¹,Coutinho Diego¹,Kayani Jehanzeb¹,Chernak Brian¹,Lane Joseph⁴,Hillyer Christopher⁵,Galili Naomi¹,Jurcic Joseph¹,Mohandas Narla²,An Xiuli²⁶,Raza Azra¹

Affiliation:

1. Myelodysplastic Syndromes Center, Columbia University Medical Center, Columbia University, New York, NY;

2. Laboratory of Membrane Biology, New York Blood Center, New York, NY;

3. Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;

4. Department of Orthopedic Surgery, New York Presbyterian Cornell Hospital, New York NY;

5. Laboratory of Red Cell Physiology, New York Blood Center, New York, NY; and

6. School of Life Science, Zhengzhou University, Zhengzhou, China

Abstract

Key Points TED is defective in patients with MDS. TED is an independent prognostic factor for survival in MDS.

Publisher

American Society of Hematology

Subject